anmelden
SPI
18.736,02
PKT
+51,78
PKT
+0,28
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.07.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 24.07.18 | ams-OSRAM Outperform | Credit Suisse Group | |
| 24.07.18 | ams-OSRAM overweight | JP Morgan Chase & Co. | |
| 23.07.18 | Holcim Neutral | JP Morgan Chase & Co. | |
| 23.07.18 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 23.07.18 | UBS Neutral | Goldman Sachs Group Inc. | |
| 23.07.18 | UBS buy | Goldman Sachs Group Inc. | |
| 23.07.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.07.18 | Givaudan Hold | Kepler Cheuvreux | |
| 23.07.18 | Swiss Re Outperform | Credit Suisse Group | |
| 23.07.18 | Swiss Re Hold | Deutsche Bank AG | |
| 23.07.18 | ABB (Asea Brown Boveri) Neutral | Citigroup Corp. | |
| 23.07.18 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 23.07.18 | Holcim Sell | Société Générale Group S.A. (SG) | |
| 23.07.18 | Holcim Sell | Société Générale Group S.A. (SG) | |
| 23.07.18 | UBS Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.07.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 23.07.18 | UBS buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.07.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.07.18 | Roche overweight | JP Morgan Chase & Co. | |
| 20.07.18 | ABB (Asea Brown Boveri) buy | Kepler Cheuvreux | |
| 20.07.18 | Givaudan buy | Baader Bank | |
| 20.07.18 | Givaudan verkaufen | Bernstein Research | |
| 20.07.18 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.07.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 20.07.18 | Novartis Neutral | UBS AG | |
| 19.07.18 | Roche buy | Baader Bank | |
| 19.07.18 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 19.07.18 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 19.07.18 | UBS Outperform | Credit Suisse Group | |
| 19.07.18 | Novartis Neutral | Credit Suisse Group | |
| 19.07.18 | Roche overweight | JP Morgan Chase & Co. | |
| 19.07.18 | Novartis kaufen | DZ BANK | |
| 19.07.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 19.07.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.07.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.07.18 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 19.07.18 | Novartis Equal weight | Barclays Capital | |
| 19.07.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 19.07.18 | Novartis Neutral | UBS AG |